Yuanqi Bio announced the completion of a $110 million Pre-IPO financing round.

Yuanqi Biosciences announced that it has completed a cumulative $110 million Pre-IPO round of financing. The funds raised in this round will be mainly used to accelerate the international strategic layout of Yuanqi Biosciences and promote the global multi-center clinical development of its core pipeline.